Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03023319
Title Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nagla Karim
Indications

lung non-small cell carcinoma

ovarian cancer

cervical cancer

peritoneum cancer

thymus cancer

urethra cancer

urinary bladder cancer

thymoma

malignant pleural mesothelioma

Therapies

Bosutinib + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.